Combination of a biopharmaceutic classification system and physiologically based pharmacokinetic models to predict absorption properties of baicalein in vitro and in vivo

被引:1
|
作者
Yang Liu [1 ]
Jing Sun [2 ]
Linying Zhong [1 ]
Yu Li [2 ]
A Na Er [2 ]
Tong Li [1 ]
Le Yang [2 ]
Ling Dong [1 ]
机构
[1] School of Life Sciences, Beijing University of Chinese Medicine
[2] College of Chinese Material Medica, Beijing University of Chinese Medicine
基金
中国国家自然科学基金;
关键词
D O I
暂无
中图分类号
R285 [中药药理学];
学科分类号
摘要
Objective: To determine the in vitro and in vivo absorption properties of active ingredients of the Chinese medicine, baicalein, to enrich mechanistic understanding of oral drug absorption.Methods: The Biopharmaceutic Classification System(BCS) category was determined using equilibrium solubility, intrinsic dissolution rate, and intestinal permeability to evaluate intestinal absorption mechanisms of baicalein in rats in vitro. Physiologically based pharmacokinetic(PBPK) model commercial software GastroPlusTMwas used to predict oral absorption of baicalein in vivo.Results: Based on equilibrium solubility, intrinsic dissolution rate, and permeability values of main absorptive segments in the duodenum, jejunum, and ileum, baicalein was classified as a drug with low solubility and high permeability. Intestinal perfusion with venous sampling(IPVS) revealed that baicalein was extensively metabolized in the body, which corresponded to the low bioavailability predicted by the PBPK model. Further, the PBPK model predicted the key indicators of BCS, leading to reclassification as BCS-II. Predicted values of peak plasma concentration of the drug(Cmax) and area under the curve(AUC)fell within two times of the error of the measured results, highlighting the superior prediction of absorption of baicalein in rats, beagles, and humans. The PBPK model supported in vitro and in vivo evidence and provided excellent prediction for this BCS class II drug.Conclusion: BCS and PBPK are complementary methods that enable comprehensive research of BCS parameters, intestinal absorption rate, metabolism, prediction of human absorption fraction and bioavailability, simulation of PK, and drug absorption in various intestinal segments across species. This combined approach may facilitate a more comprehensive and accurate analysis of the absorption characteristics of active ingredients of Chinese medicine from in vitro and in vivo perspectives.
引用
收藏
页码:238 / 247
页数:10
相关论文
共 50 条
  • [1] Forecasting oral absorption across biopharmaceutics classification system classes with physiologically based pharmacokinetic models
    Hansmann, Simone
    Darwich, Adam
    Margolskee, Alison
    Aarons, Leon
    Dressman, Jennifer
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2016, 68 (12) : 1501 - 1515
  • [2] Integration of In Vitro and In Vivo Models to Predict Cellular and Tissue Dosimetry of Nanomaterials Using Physiologically Based Pharmacokinetic Modeling
    Lin, Zhoumeng
    Aryal, Santosh
    Cheng, Yi-Hsien
    Gesquiere, Andre J.
    ACS NANO, 2022, 16 (12) : 19722 - 19754
  • [3] Physiologically Based In vitro Models to Predict the Oral Dissolution and Absorption of a Solid Drug Delivery System
    Li, Ziqiang
    He, Xin
    CURRENT DRUG METABOLISM, 2015, 16 (09) : 777 - 806
  • [4] Physiologically Based Pharmacokinetic Models Can Be Used to Predict the Unique Nonlinear Absorption Profiles of Vismodegib
    Lin, Louis
    Wright, Matthew R.
    Hop, Cornelis E. C. A.
    Wong, Harvey
    DRUG METABOLISM AND DISPOSITION, 2022, 50 (09) : 1170 - 1181
  • [5] In vitro and in vivo anti-inflammatory, antibacterial and pharmacokinetic properties of baicalein
    Varia, Raseshkumar D.
    Patel, Jatin H.
    Modi, Falguni D.
    Vihol, Priti D.
    Bhavsar, Shailesh K.
    VETERINARSKI ARHIV, 2023, 93 (01) : 117 - 128
  • [6] Physiologically Based Pharmacokinetic and Physiologically Based Biopharmaceutic models research in Latin America: A regional level bibliometric analysis, 2011-2023
    Ribeiro, Marx
    Cardoso, Juliana Cordeiro
    Martins, Jose Eduardo Severino
    Pinto, Aline Ferreira
    Souto, Eliana Maria Barbosa
    Severino, Patricia
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2025, 61
  • [7] In Vitro to In Vivo Extrapolation Linked to Physiologically Based Pharmacokinetic Models for Assessing the Brain Drug Disposition
    Yukiko Murata
    Sibylle Neuhoff
    Amin Rostami-Hodjegan
    Hiroyuki Takita
    Zubida M. Al-Majdoub
    Kayode Ogungbenro
    The AAPS Journal, 24
  • [8] Development of physiologically based pharmacokinetic (PBPK) models for quantitative in vitro-in vivo extrapolations (QIVIVE)
    Punt, A.
    TOXICOLOGY LETTERS, 2022, 368 : S5 - S5
  • [9] In Vitro to In Vivo Extrapolation Linked to Physiologically Based Pharmacokinetic Models for Assessing the Brain Drug Disposition
    Murata, Yukiko
    Neuhoff, Sibylle
    Rostami-Hodjegan, Amin
    Takita, Hiroyuki
    Al-Majdoub, Zubida M.
    Ogungbenro, Kayode
    AAPS JOURNAL, 2022, 24 (01):
  • [10] Biopharmaceutic In Vitro In Vivo Extrapolation (IVIV_E) Informed Physiologically-Based Pharmacokinetic Model of Ritonavir Norvir Tablet Absorption in Humans Under Fasted and Fed State Conditions
    Arora, Sumit
    Pansari, Amita
    Kilford, Peter
    Jamei, Masoud
    Gardner, Iain
    Turner, David B.
    MOLECULAR PHARMACEUTICS, 2020, 17 (07) : 2329 - 2344